Shoji Fujitani
Overview
Explore the profile of Shoji Fujitani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morita R, Ohta M, Hayabuchi H, Fujitani S, Yoshida S, Matsumoto H, et al.
Hypertens Res
. 2020 Feb;
43(6):579-581.
PMID: 32071441
No abstract available.
2.
Hayabuchi H, Morita R, Ohta M, Nanri A, Matsumoto H, Fujitani S, et al.
Hypertens Res
. 2020 Jan;
43(6):525-533.
PMID: 31996813
Sodium reduction is an important public health goal. Individual and population approaches are necessary for reducing the sodium content of processed foods and meals. The aim of the present study...
3.
Sugimoto M, Murakami K, Fujitani S, Matsumoto H, Sasaki S
Nutr Res
. 2019 Apr;
67:67-77.
PMID: 30979663
Glutamate is naturally present in various foods, such as many savory foods. Therefore, we hypothesized that dietary free glutamate comes from a variety of foods in the United States. The...
4.
Shibui Y, Fujitani S, Iwata H, Lynch B, Roberts A
Regul Toxicol Pharmacol
. 2018 Dec;
102:23-29.
PMID: 30572082
Researchers from the Ramazzini Institute have reported that lifespan dosing of rats with aspartame treatment is associated with an increased overall incidence of malignant tumors, including leukemias/lymphomas, transitional cell carcinomas...
5.
Hagiwara A, Ishizaki S, Takehana K, Fujitani S, Sonaka I, Satsu H, et al.
Amino Acids
. 2014 Feb;
46(5):1275-83.
PMID: 24553827
Taurine deficiency has been suggested to contribute to the pathogenesis and complications of advanced hepatic diseases. The molecular basis for a low level of taurine associated with hepatic failure is...
6.
Matsumura T, Morinaga Y, Fujitani S, Takehana K, Nishitani S, Sonaka I
Hepatol Res
. 2005 Sep;
33(1):27-32.
PMID: 16169275
BCAA granules (a mixture of branched-chain amino acids) have been used to reverse the hypoalbuminemia of decompensated liver cirrhotic patients in Japan. Our previous studies showed that BCAA promoted albumin...
7.
Nishitani S, Takehana K, Fujitani S, Sonaka I
Am J Physiol Gastrointest Liver Physiol
. 2004 Dec;
288(6):G1292-300.
PMID: 15591158
It is well established that impaired glucose metabolism is a frequent complication in patients with hepatic cirrhosis. We previously showed that leucine, one of the branched-chain amino acids (BCAA), promotes...
8.
Nishitani S, Ijichi C, Takehana K, Fujitani S, Sonaka I
Biochem Biophys Res Commun
. 2003 Dec;
313(2):387-9.
PMID: 14684173
Branched-chain amino acid (BCAA: Leu, Ile, and Val) mixture has been used for treatment of hypoalbuminemia in patients with decompensated liver cirrhosis in Japan. It has been known that BCAA,...
9.
Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K
Biochem Biophys Res Commun
. 2002 Dec;
299(5):693-6.
PMID: 12470633
Soleus muscles isolated from normal rats were incubated to evaluate whether or not leucine promotes glucose uptake under insulin-free conditions, using a labeled 2-deoxyglucose uptake assay. Glucose uptake was promoted...
10.
Ishizaki-Koizumi S, Sonaka I, Fujitani S, Nishiguchi S
Biochem Biophys Res Commun
. 2002 Feb;
291(4):738-43.
PMID: 11866426
The addition of L-alanine reduced lactate dehydrogenase leakage from primary cultured rat hepatocytes treated with galactosamine (D-gal), while D-alanine and other amino acids did not. However, the mechanisms have not...